Ro: the startup’s technological approach to telehealth
Ro is a New York-based healthcare technology company operating in areas from telemedicine to remote diagnosis.
The company has three digital health clinics, one for women’s health, one for men’s health and one for stopping smoking. It also operates an online, cash-pay pharmacy and a weight management aid.
The company says it has seen more than five million digital healthcare visits, with all its services requiring no insurance.
Since its foundation in 2017, the company has raised across four funding rounds. Its latest Series C round, announced just yesterday, saw the company in funding from lead investor General Catalyst, alongside Torch Capital, TQ Ventures, TCG, SignalFire, Initialized Capital FirstMark, BoxGroup and 3L Capital.
In a press release, Zachariah Reitano, Co-Founder & CEO of Ro, said: “Every single person deserves high-quality, affordable healthcare. At Ro, we believe the only way to do this is by putting patients at the center of their care and building technology to empower providers to do what they do best — help people. This new investment will further our mission to become every patient’s first call. We’ll continue to invest in our vertically-integrated healthcare ecosystem, from our Collaborative Care Center to our national pharmacy operating system. This is just the beginning of Ro’s patient-centered healthcare platform.”
The company said it would use the funds to further build its technology portfolio, including offering remote patient monitoring from integrated devices, and double the size of its engineering team.
Dr. Joycelyn Elders, MD, Ro Medical Advisor and Former US Surgeon General, said: “Telehealth companies like Ro are using technology to address long-standing healthcare disparities that have been exacerbated by Covid-19. By empowering providers to leverage their skills as efficiently and effectively as possible, Ro delivers affordable, high-quality care regardless of a patient’s location, insurance status, or physical access to physicians and pharmacies.”